Buchumschlag

Editorial: Mucosal healing with steroids—Once upon a time in ulcerative colitis. Authors' reply

Fuente: Wiley Open Access

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	Tomohiro Fukuda, Hajime Yamazaki, Katsuyoshi Matsuoka
Format:	Artículo Open Access
Veröffentlicht:	Wiley 2024
Schlagworte:	Alimentary Pharmacology & Therapeutics
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Editorial: Mucosal healing with steroids: Once upon a time in ulcerative colitis
von: Manuel Barreiro‐de Acosta, et al.
Veröffentlicht: (2024)

Recent steroid use and the relapse risk in ulcerative colitis patients with endoscopic healing
von: Tomohiro Fukuda, et al.
Veröffentlicht: (2024)

Editorial: Sequencing rescue therapy for acute severe ulcerative colitis—Ready for revision? Authors' reply
von: María José García, et al.
Veröffentlicht: (2024)

Letter: Should ulcerative colitis be monitored more or less invasively? Authors' reply
von: Matthias Lenfant, et al.
Veröffentlicht: (2024)

Editorial: Extending upadacitinib induction dosing in ulcerative colitis—A delicate balance of efficacy and safety. Author's reply
von: Remo Panaccione
Veröffentlicht: (2024)

Letter: Third‐line therapy in acute severe ulcerative colitis, exploring the uncertainty and unanswered questions—Authors' reply
von: María José García, et al.
Veröffentlicht: (2024)

Letter: Critical appraisal of biologic therapy in early ulcerative colitis management—Addressing study limitations and the role of psychological resilience—Authors' reply
von: Vibeke Strande, et al.
Veröffentlicht: (2024)

Editorial: Quantity is important! Authors' reply
von: Marika Rudler, et al.
Veröffentlicht: (2024)

Letter: Potential confounders might exaggerate the risk of rheumatoid arthritis in patients with microscopic colitis—Authors' reply
von: David Bergman, et al.
Veröffentlicht: (2024)

Editorial: Another brick in the CDST wall: Authors' reply
von: Kyuwon Kim, et al.
Veröffentlicht: (2024)

Editorial: Sequencing rescue therapy for acute severe ulcerative colitis—Ready for revision?
von: L. A. A. P. Derikx, et al.
Veröffentlicht: (2024)

Editorial: Crystalising the burden of steatotic liver disease—Authors' reply
von: Carolin V. Schneider, et al.
Veröffentlicht: (2024)

Editorial: Recompensation in PBC is good. But is it good enough? Authors' reply
von: Benedikt Silvester Hofer, et al.
Veröffentlicht: (2024)

Editorial: Effectiveness and safety of ustekinumab in ulcerative colitis—Where we are now in real life
von: Giammarco Mocci, et al.
Veröffentlicht: (2024)

Editorial: The microbiome and gastric mucosal protection in aspirin users—Authors' reply
von: Nina Løn, et al.
Veröffentlicht: (2024)

Editorial: Extending upadacitinib induction dosing in ulcerative colitis‐A delicate balance of efficacy and safety
von: Shintaro Sagami, et al.
Veröffentlicht: (2024)

Letter: Should ulcerative colitis be monitored more or less invasively?
von: David Laharie
Veröffentlicht: (2024)

Editorial: High qHBsAg—Is it a good or bad signal? Authors' reply
von: Hsin‐Che Lin, et al.
Veröffentlicht: (2024)

Editorial: Can we predict or not predict response to hypnotherapy? That is the question. Authors' reply
von: Dipesh H. Vasant, et al.
Veröffentlicht: (2024)

Editorial: Revisit the causes and long‐term outcomes in cirrhosis patients—Authors' reply
von: Linda Henry, et al.
Veröffentlicht: (2024)

Editorial: How does the risk of hepatocellular carcinoma change over time in patients with a hepatitis C cure? Authors' reply
von: Philip Vutien, et al.
Veröffentlicht: (2024)

Editorial: Genetics for non‐invasive risk stratification—Finding the needle in the haystack? Authors' reply
von: Lana Bridi, et al.
Veröffentlicht: (2024)

Editorial: Mortality in immune‐mediated inflammatory diseases during early adulthood—Authors' reply
von: Mikkel Malham, et al.
Veröffentlicht: (2024)

Editorial: Sonographic assessment of colonic content—A new tool for constipation? Authors' reply
von: R. M. Mathias, et al.
Veröffentlicht: (2024)

Editorial: Emulsifiers and thickeners in our food—Do they alter gut permeability? Authors' reply
von: Jessica A. Fitzpatrick, et al.
Veröffentlicht: (2024)

Editorial: Hepatitis C virus eradication improves skeletal muscle mass—Authors' reply
von: Marta Paula Pereira Coelho, et al.
Veröffentlicht: (2024)

Letter: Irritable bowel syndrome and antibiotics—Authors' reply
von: Kyle Staller, et al.
Veröffentlicht: (2024)

Long‐term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study
von: María Chaparro, et al.
Veröffentlicht: (2024)

Predicting complications in paediatric ulcerative colitis: A longitudinal multicentre cohort study
von: Merle Claßen, et al.
Veröffentlicht: (2024)

Editorial: The tsunami of steatotic liver disease in India, the Asia‐Pacific region and the world—Authors' reply
von: Manya Prasad, et al.
Veröffentlicht: (2024)

Editorial: Eosinophilic oesophagitis coming of age—Increasing frequency and wider age range—Authors' reply
von: Akshatha Kiran, et al.
Veröffentlicht: (2024)

Editorial: Reading the cholate—A new gateway to portal hypertension and oesophageal varices: Authors' reply
von: Tarek Hassanein, et al.
Veröffentlicht: (2024)

Editorial: Diagnosis of GERD in patients with extra‐oesophageal symptoms—still a long way to go… Authors' reply'
von: Francesco Calabrese, et al.
Veröffentlicht: (2024)

A personalised algorithm predicting the risk of intravenous corticosteroid failure in acute ulcerative colitis
von: Anthony Croft, et al.
Veröffentlicht: (2024)

Editorial: Redefining liver health—Personalised approach to assessment of serum ALT in clinical practice. Authors' reply
von: Eunice X. X. Tan, et al.
Veröffentlicht: (2024)

Editorial: Updated epidemiology of steatotic liver disease in people withHIVin the United States—Authors' reply
von: Samer Gawrieh, et al.
Veröffentlicht: (2024)

Editorial: Infliximab induction therapy in paediatric Crohn's disease — A cost‐effective strategy? Authors' reply
von: Stephanie A. Vuijk, et al.
Veröffentlicht: (2024)

Letter: The enigma of angiotensin receptor blocker‐associated enteropathy—Authors' reply
von: Annalisa Schiepatti, et al.
Veröffentlicht: (2024)

Editorial: Shorter course of intravenous terlipressin in acute variceal bleeding—the promise, controversies and future directions. Author's reply
von: Sagnik Biswas, et al.
Veröffentlicht: (2024)

Efficacy and safety of filgotinib for ulcerative colitis: A real‐world multicenter retrospective study in Japan
von: Shintaro Akiyama, et al.
Veröffentlicht: (2024)